Suppr超能文献

肾切除术后肾细胞癌的局部复发

[Local recurrence of renal cell carcinoma after nephrectomy].

作者信息

Pereverzev A S, Shchukin D V, Iliukhin Iu A

出版信息

Urologiia. 2003 Nov-Dec(6):14-8.

Abstract

Despite significant advances in surgical oncourology, local recurrence of renal cell carcinoma (RCC) remains a serious problem both for the doctor and the patient. Our study of treatment outcomes in local recurrent RCC consisted in a retrospective analysis of 13 patients with a local RCC recurrence in the renal fossa treated with surgical resection alone between 1991 and 2003. Twelve patients demonstrated no evidence of distant metastases at the time of the recurrence. One patient had a synchronous metastasis to the contralateral adrenal gland. A mean recurrence-free interval was 14.6 months (range 2-96 months) after nephrectomy. 46% patients demonstrated symptoms of weight loss, fatigue and lumbar pains. The source of local recurrence in 2 patients was metachronous metastases to the ipsylateral adrenal gland, in 1 patients--a tumor thrombus in the remnant of the left renal vein, in 3--soft tissues of the renal fossa and in 7--metastases to the regional lymph nodes. 13 resections were performed with one intraoperative death and one immediate postoperative death. Splenectomy was made in 2 patients, resection of the stomach in 1, distal pancreatectomy in 1, resection of the inferior vena cava in 3, aorta in 1. The average blood loss was 800 ml (300-4500 ml). Up to now 6 patients survived. Of 5 decreased patients 4 died of progressive disease in 1, 4, 10 and 16 months. 1 patient died of cause unrelated to cancer recurrence in 14 months. Out of 6 alive patients 4 have no signs of the disease for, on the average, 31.6 months (range 4-78 months) and 2 patients have obvious progression of the disease (1--repeated local recurrence, 1--distant metastases) 9 and 15 months after the operation. We believe that an aggressive surgical approach to a local RCC recurrence can produce an increase in disease-free survival and significantly improve quality of life for such patients.

摘要

尽管外科肿瘤泌尿学取得了重大进展,但肾细胞癌(RCC)的局部复发对医生和患者来说仍然是一个严重问题。我们对局部复发性RCC治疗结果的研究包括对1991年至2003年间仅接受手术切除治疗的13例肾窝局部RCC复发患者进行回顾性分析。12例患者在复发时未发现远处转移证据。1例患者同时出现对侧肾上腺转移。肾切除术后平均无复发生存期为14.6个月(范围2 - 96个月)。46%的患者出现体重减轻、疲劳和腰痛症状。2例患者的局部复发源为同侧肾上腺异时性转移,1例为左肾静脉残余中的肿瘤血栓,3例为肾窝软组织,7例为区域淋巴结转移。共进行了13例手术,术中死亡1例,术后立即死亡1例。2例患者进行了脾切除术,1例进行了胃切除术,1例进行了远端胰腺切除术,3例进行了下腔静脉切除术,1例进行了主动脉切除术。平均失血量为800毫升(300 - 4500毫升)。截至目前,6例患者存活。在5例病情恶化的患者中,4例分别在1、4、10和16个月死于疾病进展。1例患者在14个月时死于与癌症复发无关的原因。在6例存活患者中,4例平均31.6个月(范围4 - 78个月)无疾病迹象,2例患者在术后9个月和15个月出现明显疾病进展(1例为局部复发,1例为远处转移)。我们认为,对局部RCC复发采取积极的手术方法可以提高无病生存率,并显著改善此类患者的生活质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验